We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Lab901 Announces True at-Line Monitoring of Monoclonal Antibody Production by SDS-PAGE
Product News

Lab901 Announces True at-Line Monitoring of Monoclonal Antibody Production by SDS-PAGE

Lab901 Announces True at-Line Monitoring of Monoclonal Antibody Production by SDS-PAGE
Product News

Lab901 Announces True at-Line Monitoring of Monoclonal Antibody Production by SDS-PAGE


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Lab901 Announces True at-Line Monitoring of Monoclonal Antibody Production by SDS-PAGE"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Lab901 announced at the Peptalk 2010 conference that its Protein ScreenTape® platform can deliver, for the first time, true, practical at-line monitoring of monoclonal antibody production.

Before now, at-line monitoring of antibody production by SDS PAGE has been impractical with other existing platforms as the cost per test-point is too high or the analysis takes too long to be of value.

With its staining protocol and automated sample handling, electrophoresis and data presentation, the Protein ScreenTape platform can deliver information on yield, purity and molecular weight within a few minutes. Samples can be analysed directly from the bioreactor with no need to purify or filter the media.

Analysis of media containing high levels of serum is also possible using ScreenTape. Lab901 application scientist Adam Inche said, “This information will be invaluable not only for process optimization, but also for batch monitoring as it is now possible to assess antibody production by SDS-PAGE on a day-by-day, or even hour-by-hour basis. This data will enable our clients to make more informed decisions on when to harvest their bioreactor batch, thus saving time and money.”
Advertisement